Sector: Life Sciences

Recently we ran a blog on the most frequent filers of IPRs at the USPTO’s Patent Trial and Appeal Board. Not surprisingly the list was dominated by large tech companies such as Apple, Google, Samsung and Microsoft, all of which frequently find…

12 March 2015

A drug developed by a subsidiary of Fujifilm has shown some efficacy in the treatment of patients infected with the extremely contagious – and usually deadly – ebola virus, according to recent reports. The compound – Favipiravir – is manufactured by…

12 March 2015

When this blog asked members of the patent community to single out which part of the America Invents Act had made the most the impact, the new inter partes review (IPR) process at the renamed Patent Trial and Appeal Board (PTAB) was the unanimous…

09 March 2015

The National People’s Congress (NPC) – China’s legislature – convened in Beijing this week for its annual meeting. While its counterpart sitting in Washington DC mulls over its own patent reform proposals, the NPC has the prospective overhaul of…

06 March 2015

With competing bills in Congress and lobbying dollars pouring into the fight, it’s fair to say that the patent reform debate is heating up. Earlier this week a coalition of groups including the Association of American Universities, the Association…

05 March 2015

Details of the Chinese National Development and Reform Commission’s settlement of its antitrust probe of Qualcomm emerged last week, with the US company slated to pay a $975 million fine and facing significant limitations on its patent licensing…

16 February 2015

LG Group – one of South Korea’s largest chaebol (conglomerates) and parent of companies including LG Electronics, LG Chem and LG Display, among others – announced last week that it would ‘open up’ part of its patent portfolio for use by third…

13 February 2015

Those of us who read the predictions for 2015 that Erich Spangenberg made on the IPNav blog on the final day of last year were probably not too surprised to find out yesterday that he has teamed up with activist shareholder and hedge fund owner Kyle…

11 February 2015

China often hogs the limelight when it comes to discussion about which emerging economy will become the next major IP market alongside the United States and Europe. Questions over the Indian authorities’ approach to IP rights have no doubt…

06 February 2015

China’s desperate need for more IP strategy expertise is an issue that this blog has addressed on several occasions previously. A story IAM heard from a senior IP executive at a Chinese pharmaceutical manufacturer last week drives the point home.…

05 February 2015